A new study warns that US pressure to lower drug prices could force Switzerland to raise its own, potentially costing households hundreds of millions of francs annually. Researchers say this 'most-favoured nation' dynamic may compel Swiss authorities to accept higher prices to maintain access to innovative medicines.
in News